"The company said before the open that a poster presentation of five-year data for the GP2 clinical trial met all of its endpoints and showed zero recurrence of breast cancer in patients who had previously undergone surgery."
Don't want to take this away from patients as everything that helps is welcome but:
Zero recurrence after surgery, while Her-Vaxx / CF 33 do not need surgery to kill and prevent from recurring. That is the benchmark to be compared with. Now that alone should send IMU to at least $1.
But instead getting crashed again.
Media Thread, page-430
-
- There are more pages in this discussion • 14,769 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.4¢ | 5.4¢ | $4.947K | 91.60K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 361582 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 605449 | 12 |
View Market Depth
| Last trade - 10.04am 22/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |